Although less common, NTHi (approximately 3% of isolates) also express receptors that directly recognise and extract iron from transferrin and/or lactoferrin ( in vivo (Morton et al., 2010a)
The US Food and Drug Administration approved metformin to treat Type 2 diabetes almost thirty years ago, but it's not officially considered a weight loss drug
(2025) GLP-1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk, Obesity Reviews Advocacy and Clinical Organizations National Eating Disorders Association (NEDA) GLP-1 Medications and Eating Disorders ANAD GLP-1 Medications & Eating Disorders Clinical and News Sources Medscape (April 2025) GLP-1 RAs in Eating Disorders: Promising or Perilous? NPR (February 2026) GLP-1 obesity drugs and eating disorders are not well understood yet National Geographic (November 2025) Doctors are worried about prescribing GLP-1s to certain patients NBC News (August 2024) Eating disorders rise amid popular weight loss medications Wegovy and Zepbound
It is retained far longer, allowing a two to three month maintenance interval instead of frequent repeat dosing.
Great service and packaging The customer support was helpful and everything arrived nicely wrapped
In those patients, subjective improvement in GI symptoms typically appears within the first 30 days of a subcutaneous BPC-157 protocol
.jpg)
